報價延遲最少15分鐘:2025/11/20 23:53 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
27.67 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.16/-0.49
|
|
企業價值
2.47B
|
| 資產負債 |
|
每股賬面淨值
2.99
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
125.81M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/11/20 23:53 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derivesmaximum revenue from United States. |
